| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ABBVIE INC | 156 | 10,000 | 0.00% | ||
| 2 | OncoGenex Pharmaceuticals Inc | 113,100 | 264,000 | 0.01% | ||
| 3 | KITE PHARMA INCORPORATED | 6,300 | 384,000 | 0.01% | ||
| 4 | XENCOR INC COM | 20,000 | 439,000 | 0.02% | ||
| 5 | ZAFGEN INC COM | 13,307 | 461,000 | 0.02% | ||
| 6 | MACROGENICS INC | 12,743 | 484,000 | 0.02% | ||
| 7 | ADAPTIMMUNE THERAPEUTICS PLC | 27,500 | 504,000 | 0.02% | ||
| 8 | CIDARA THERAPEUTICS INC | 50,000 | 701,000 | 0.03% | ||
| 9 | SANGAMO THERAPEUTICS INCORPORATED | 75,000 | 832,000 | 0.03% | ||
| 10 | GALAPAGOS NV | 20,000 | 1,030,000 | 0.04% | ||
| 11 | INTELLIPHARMACEUTICS INTL IN | 354,047 | 1,041,000 | 0.04% | ||
| 12 | SAGE THERAPEUTICS INC | 15,000 | 1,095,000 | 0.04% | ||
| 13 | Abaxis Inc | 22,466 | 1,157,000 | 0.04% | ||
| 14 | BELLICUM PHARMACEUTICALS INCORPORATED | 60,000 | 1,276,000 | 0.05% | ||
| 15 | TRILLIUM THERAPEUTICS INC | 65,000 | 1,418,000 | 0.05% | ||
| 16 | CELLECTIS S A | 40,000 | 1,443,000 | 0.05% | ||
| 17 | DERMIRA INC COM | 97,197 | 1,706,000 | 0.06% | ||
| 18 | GENMARK DIAGNOSTICS INC. | 215,149 | 1,949,000 | 0.07% | ||
| 19 | BIODELIVERY SCIENCES INTL IN | 250,000 | 1,990,000 | 0.07% | ||
| 20 | MYRIAD GENETICS INC | 74,800 | 2,542,000 | 0.09% | ||
| 21 | TETRALOGIC PHARMACEUTICALS C | 4,500,000 | 2,658,000 | 0.10% | PRN | |
| 22 | MERRIMACK PHARMACEUTI | 1,485,000 | 3,113,000 | 0.11% | PRN | |
| 23 | ACCELERATE DIAGNOSTICS INC | 144,625 | 3,733,000 | 0.14% | ||
| 24 | AEGERION PHARMACEUTICALS INC | 206,000 | 3,908,000 | 0.14% | ||
| 25 | FLEX PHARMA INC COM | 232,600 | 4,001,000 | 0.14% | ||
| 26 | WRIGHT MEDICAL GROUP NV | 156,100 | 4,099,000 | 0.15% | ||
| 27 | KYTHERA BIOPHARMACEUTICALS I | 55,717 | 4,196,000 | 0.15% | ||
| 28 | FOAMIX PHARMACEUTICALS LTD | 413,800 | 4,241,000 | 0.15% | ||
| 29 | SPECTRUM PHARMACEUTICALS INC | 5,000,000 | 4,694,000 | 0.17% | PRN | |
| 30 | EPIZYME INC COM | 200,000 | 4,800,000 | 0.17% | ||
| 31 | ACHILLION PHARMACEUTICALS IN | 547,300 | 4,849,000 | 0.18% | ||
| 32 | ALLERGAN PLC | 5,000 | 5,213,000 | 0.19% | ||
| 33 | IONIS PHARMACEUTICAL | 98,200 | 5,651,000 | 0.20% | ||
| 34 | IONIS PHARMACEUTICAL | 98,200 | 5,651,000 | 0.20% | Call | |
| 35 | ENDO INTL PLC | 74,100 | 5,902,000 | 0.21% | Call | |
| 36 | HCA HOLDINGS INC | 66,300 | 6,015,000 | 0.22% | Call | |
| 37 | TENET HEALTHCARE CORP | 105,000 | 6,077,000 | 0.22% | Call | |
| 38 | MEDIVATION INC | 53,700 | 6,133,000 | 0.22% | Call | |
| 39 | MEDIVATION INC | 53,700 | 6,133,000 | 0.22% | ||
| 40 | ULTRAGENYX PHARMACEUTICAL INC COM | 60,000 | 6,143,000 | 0.22% | ||
| 41 | ZOGENIX INC | 3,800,811 | 6,385,000 | 0.23% | ||
| 42 | SUPERNUS PHARMACEUTICALS INC | 2,000,000 | 6,655,000 | 0.24% | PRN | |
| 43 | BLUEBIRD BIO INC COM | 40,895 | 6,885,000 | 0.25% | ||
| 44 | SANOFI SPOND FUNSPONSORED ADR | 567,787 | 7,021,000 | 0.25% | ||
| 45 | INTRA-CELLULAR THERAPIES INC | 227,164 | 7,258,000 | 0.26% | ||
| 46 | WELLCARE HEALTH PLANS INC | 88,652 | 7,520,000 | 0.27% | ||
| 47 | SENIOR HOUSING PROPERTIES TRUST | 479,604 | 8,417,000 | 0.30% | ||
| 48 | ENDOLOGIX INC | 551,000 | 8,452,000 | 0.31% | ||
| 49 | IDEXX LAB | 132,352 | 8,489,000 | 0.31% | ||
| 50 | ALLIQUA BIOMEDICAL INC | 1,650,000 | 8,696,000 | 0.31% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001104659-15-058926, filed 2015.08.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
